🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
EPS Bio Technology Corp. (TPEX:4183)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.25
-1.20 (-8.30%)
Nov 20, 2026, 1:30 PM CST

EPS Bio Technology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
135.63123.08128.94195.29178.66203.42
Cash & Short-Term Investments
135.63123.08128.94195.29178.66203.42
Cash Growth
23.36%-4.55%-33.97%9.31%-12.17%-8.32%
Accounts Receivable
86.79150.35149.892.0978.81101.23
Other Receivables
4.35.984.882.972.272.78
Receivables
91.09156.33154.6795.0581.08104.01
Inventory
78.9373.2481.0672.6786.4581.56
Prepaid Expenses
-2.763.153.181.544.06
Other Current Assets
2.030.060.170.150.060.05
Total Current Assets
307.68355.47368366.33347.77393.1
Property, Plant & Equipment
179.2169.51167.86163.14172.32173.57
Other Intangible Assets
3.762.971.841.963.645.41
Long-Term Deferred Tax Assets
2.12.191.593.381.852.38
Other Long-Term Assets
0.83.12.618.362.183
Total Assets
493.54533.25541.9543.16527.76577.45

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
69.9972.7380.6474.5458.3181.38
Accrued Expenses
-20.9425.0227.0226.3326.88
Short-Term Debt
3040----
Current Portion of Long-Term Debt
-2.642.592.552.522.54
Current Portion of Leases
3.473.093.163.143.083.01
Current Income Taxes Payable
---7.286.658.96
Current Unearned Revenue
4.318.5413.193.791.629.29
Other Current Liabilities
26.036.675.266.714.835.12
Total Current Liabilities
133.79154.62129.85125.03103.32157.17
Long-Term Debt
5.757.7610.412.9815.5218.02
Long-Term Leases
93.9287.2693.9997.15100.28102.91
Long-Term Unearned Revenue
1.081.622.351.78--
Long-Term Deferred Tax Liabilities
-0.880.760.180.280.08
Total Liabilities
234.54252.14237.34237.13219.41278.18

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
238238238238238238
Additional Paid-In Capital
31.631.631.631.631.631.6
Retained Earnings
-10.611.5134.9536.4438.7629.67
Shareholders' Equity
259281.11304.55306.04308.36299.27
Total Liabilities & Equity
493.54533.25541.9543.16527.76577.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
133.13140.75110.14115.82121.4126.47
Net Cash (Debt)
2.5-17.6718.8179.4757.2676.95
Net Cash Growth
-67.84%--76.34%38.80%-25.60%-14.45%
Net Cash Per Share
0.11-0.740.793.332.403.22
Filing Date Shares Outstanding
23.8623.823.823.823.823.8
Total Common Shares Outstanding
23.8623.823.823.823.823.8
Working Capital
173.89200.86238.15241.3244.45235.93
Book Value Per Share
10.8611.8112.8012.8612.9612.57
Tangible Book Value
255.24278.14302.71304.08304.72293.86
Tangible Book Value Per Share
10.7011.6912.7212.7812.8012.35
Buildings
-68.6867.8767.8768.5468.86
Machinery
-57.8745.0139.2149.0250.26
Construction In Progress
-3.142.35---